Healthcare provider profile · identity verified

Brian Paul Schulte, MD

Family Practice · BATON ROUGE, LA · NPI 1902808587

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	656	177
Amlodipine Besylate	Amlodipine Besylate	486	133
Levothyroxine Sodium	Levothyroxine Sodium	410	101
Losartan Potassium	Losartan Potassium	326	87
Pantoprazole Sodium	Pantoprazole Sodium	311	76
Metoprolol Succinate	Metoprolol Succinate	246	61
Lisinopril	Lisinopril	236	71
Gabapentin	Gabapentin	201	60
Rosuvastatin Calcium	Rosuvastatin Calcium	184	51
Metformin Hcl	Metformin Hcl	174	60
Hydrochlorothiazide	Hydrochlorothiazide	160	47
Pravastatin Sodium	Pravastatin Sodium	151	41
Omeprazole	Omeprazole	131	44
Albuterol Sulfate Hfa	Albuterol Sulfate	129	41
Fluticasone Propionate	Fluticasone Propionate	129	48
Trazodone Hcl	Trazodone Hcl	118	44
Jardiance	Empagliflozin	98	26
Olmesartan Medoxomil	Olmesartan Medoxomil	97	34
Mirtazapine	Mirtazapine	94	28
Furosemide	Furosemide	93	29
Duloxetine Hcl	Duloxetine Hcl	82	22
Escitalopram Oxalate	Escitalopram Oxalate	82	22
Ozempic	Semaglutide	81	13
Clopidogrel	Clopidogrel Bisulfate	77	19
Tamsulosin Hcl	Tamsulosin Hcl	77	25
Metformin Hcl Er	Metformin Hcl	76	26
Alendronate Sodium	Alendronate Sodium	73	19
Sertraline Hcl	Sertraline Hcl	73	20
Simvastatin	Simvastatin	70	22
Alprazolam	Alprazolam	64	13
Metoprolol Tartrate	Metoprolol Tartrate	62	18
Potassium Chloride	Potassium Chloride	59	16
Carvedilol	Carvedilol	55	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	12
Citalopram Hbr	Citalopram Hydrobromide	52	17
Ropinirole Hcl	Ropinirole Hcl	52	11
Ezetimibe	Ezetimibe	51	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	51	14
Clonazepam	Clonazepam	50	13
Allopurinol	Allopurinol	46	16
Amitriptyline Hcl	Amitriptyline Hcl	46	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	14
Synthroid	Levothyroxine Sodium	45	suppressed
Azithromycin	Azithromycin	44	39
Eliquis	Apixaban	40	13
Meloxicam	Meloxicam	36	15
Fluoxetine Hcl	Fluoxetine Hcl	34	11
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	11
Mounjaro	Tirzepatide	33	suppressed
Atenolol	Atenolol	32	suppressed
Benazepril Hcl	Benazepril Hcl	32	suppressed
Telmisartan	Telmisartan	32	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Methylprednisolone	Methylprednisolone	27	24
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	25
Ondansetron Odt	Ondansetron	25	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Ibuprofen	Ibuprofen	23	15
Ketoconazole	Ketoconazole	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Linzess	Linaclotide	21	suppressed
Lorazepam	Lorazepam	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Valsartan	Valsartan	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Nabumetone	Nabumetone	18	suppressed
Topiramate	Topiramate	18	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Finasteride	Finasteride	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Mupirocin	Mupirocin	15	13
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	13
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lactulose	Lactulose	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Naproxen	Naproxen	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	12
Glipizide	Glipizide	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	11
Labetalol Hcl	Labetalol Hcl	12	suppressed
Prednisone	Prednisone	12	12
Verapamil Er	Verapamil Hcl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Primidone	Primidone	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error